Endovascular exclusion of thoracic aortic aneurysms with the 1- and 2-component Zenith TX2 TAA endovascular grafts: Analysis of 2-year data from the TX2 pivotal trial

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose: To compare the midterm results of endovascular treatment of thoracic aortic aneurysms and ulcers in patients who received either a 1-component or 2-component Zenith TX2 stent-graft. Methods: Data were gathered from a prospectively maintained registry for the Zenith TX2 pivotal trial. Among 158 patients who underwent thoracic endovascular aortic repair (TEVAR) between March 2004 and July 2006, 64 received a 1-component stent-graft (group 1) and 94 patients a 2-component device (group 2). Results: In group 2, there were more men (79% vs. 63%; p=0.03), and the patients had more diagnosed (p

Original languageEnglish
Pages (from-to)338-349
Number of pages12
JournalJournal of Endovascular Therapy
Volume18
Issue number3
DOIs
Publication statusPublished - Jun 2011

Keywords

  • Modular device
  • Penetrating aortic ulcer
  • Stent-graft
  • Thoracic aortic aneurysm
  • Thoracic endovascular aortic repair

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Endovascular exclusion of thoracic aortic aneurysms with the 1- and 2-component Zenith TX2 TAA endovascular grafts: Analysis of 2-year data from the TX2 pivotal trial'. Together they form a unique fingerprint.

Cite this